MacLeods Pharmaceuticals Ltd.
๐ฎ๐ณIndia
- Country
- ๐ฎ๐ณIndia
- Ownership
- Private
- Established
- 1989-01-01
- Employees
- 10K
- Market Cap
- -
Clinical Trials
24
Active:0
Completed:1
Trial Phases
4 Phases
Phase 1:1
Phase 3:9
Phase 4:6
+1 more phases
Drug Approvals
12
SFDA:7
NMPA:5
Drug Approvals
Pramipexole Dihydrochloride Sustained Release Tablets
- Product Name
- ็้ ธๆฎๆๅ ็ดข็ผ้็
- Approval Number
- ๅฝ่ฏๅๅญHJ20230136
- Approval Date
- Dec 5, 2023
NMPA
Pramipexole Dihydrochloride Sustained Release Tablets
- Product Name
- ็้ ธๆฎๆๅ ็ดข็ผ้็
- Approval Number
- ๅฝ่ฏๅๅญHJ20230138
- Approval Date
- Dec 5, 2023
NMPA
Pramipexole Dihydrochloride Sustained Release Tablets
- Product Name
- ็้ ธๆฎๆๅ ็ดข็ผ้็
- Approval Number
- ๅฝ่ฏๅๅญHJ20230135
- Approval Date
- Dec 5, 2023
NMPA
Pramipexole Dihydrochloride Sustained Release Tablets
- Product Name
- ็้ ธๆฎๆๅ ็ดข็ผ้็
- Approval Number
- ๅฝ่ฏๅๅญHJ20230137
- Approval Date
- Dec 5, 2023
NMPA
Pramipexole Dihydrochloride Sustained Release Tablets
- Product Name
- ็้ ธๆฎๆๅ ็ดข็ผ้็
- Approval Number
- ๅฝ่ฏๅๅญHJ20230139
- Approval Date
- Dec 5, 2023
NMPA
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)โข Click on a phase to view related trials
Phase 3
9 (45.0%)Phase 4
6 (30.0%)Not Applicable
4 (20.0%)Phase 1
1 (5.0%)Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd
Phase 3
Not yet recruiting
- Conditions
- Mild Asthma
- Interventions
- Drug: Test PlaceboDrug: Reference Placebo
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Macleods Pharmaceuticals Ltd
- Target Recruit Count
- 144
- Registration Number
- NCT06618105
- Locations
- ๐ฎ๐ณ
Multiple Locations, Multiple Locations, India
News
No news found